Atrial Fibrillation clinical trials at UCSD
3 in progress, 2 open to eligible people
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
open to eligible people ages 18-80
To evaluate the safety and effectiveness of the Argá Medtech CSE Ablation System in the treatment of atrial fibrillation.
San Diego, California and other locations
Incidence of Long-TeRm Atrial Fibrillation After Acute Illness
open to eligible people ages 18 years and up
The investigators seek to conduct a prospective study to assess the recurrence of AF in patients with acute AF using a long-term ECG monitoring strategy with an insertable cardiac monitor (ICM), which is clinically indicated in this scenario as part of the standard of care. The investigators hypothesize that patients diagnosed with acute AF in the setting of cardiac surgery will have higher rates of AF recurrence than acute AF diagnosed in the setting of non-cardiac surgery or medical illness.
La Jolla, California
Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study
Sorry, in progress, not accepting new patients
This is a prospective, non-randomized, multi-center, real-world post-market study to collect and evaluate data regarding the performance of the enhanced atrial fibrillation detection algorithm of the Assert-IQTM Implantable Cardiac Monitor (ICM) device.
San Diego, California and other locations
Last updated: